WELL — WELL Health Technologies Cashflow Statement
0.000.00%
Last trade - 00:00
- CA$871.77m
- CA$1.33bn
- CA$776.05m
- 60
- 60
- 67
- 65
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -7.79 | -3.21 | -30.9 | 18.7 | 16.6 |
Depreciation | |||||
Deferred Taxes | |||||
Non-Cash Items | 2.68 | 0.348 | 26.1 | 8.73 | 9 |
Discontinued Operations | |||||
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.322 | -1.92 | -11.2 | -6.06 | -20.7 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Other Assets | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -2.63 | -5.38 | 22.3 | 76.5 | 65.7 |
Capital Expenditures | -0.472 | -1.13 | -2.68 | -6.4 | -8.11 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | -10.2 | -43.1 | -497 | -31.5 | -73.2 |
Acquisition of Business | |||||
Sale of Business | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -10.7 | -44.2 | -500 | -37.9 | -81.3 |
Financing Cash Flow Items | -0.808 | -6.61 | -21.2 | -28.8 | -28.1 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 26.6 | 121 | 453 | -52.8 | 10.6 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 13.3 | 71.2 | -25 | -13 | -5.49 |